Canadian Online Pharmacy

FDA Guidance Documents Update

You are subscribed to FDA Guidance Documents for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

New Guidance Document Search Feature

A new feature on the FDA.gov website allows you to search for guidance documents for all topics across the site from one convenient location:

Search all FDA official guidance documents and other regulatory guidance

Recently posted guidance documents

These draft and final guidance documents were published by the Food and Drug Administration in December 2014:

12/1/14: SUPAC: Manufacturing Equipment Addendum

12/2/14: Infusion Pumps Total Product Life Cycle - Guidance for Industry and FDA Staff

12/2/14: Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex - Guidance for Industry and Food and Drug Administration Staff

12/3/14: Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products-Content and Format

12/4/14: How to Obtain a Letter from FDA Stating that Bioequivalence Study Protocols Contain Safety Protections Comparable to Applicable REMS for RLD

12/8/14: General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products

12/8/14: DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers

12/9/14: Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format

12/10/14: VICH GL35 - Pharmacovigilance of Veterinary Medicinal Products Electronic Standards for Transfer of Data

12/11/14: Establishing Safety and Compatibility of Passive Implants in the Magnetic Resonance (MR) Environment - Guidance for Industry and Food and Drug Administration Staff

12/17/14: Providing Submissions in Electronic Format -- Standardized Study Data

12/19/14: Minimizing Risk for Children's Toy Laser Products - Guidance for Industry and Food and Drug Administration Staff

12/22/14: Transfer of a Premarket Notification (510(k)) Clearance – Questions and Answers Draft Guidance for Industry and Food and Drug Administration Staff

12/23/14: DSCSA Implementation: Product Tracing Requirements — Compliance Policy

12/30/14: Radiation Biodosimetry Devices - Draft Guidance for Industry and Food and Drug Administration Staff


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery